Skip to main content
Log in

Adverse effects of free fatty acid associated with increased oxidative stress in postischemic isolated rat hearts

  • Published:
Molecular and Cellular Biochemistry Aims and scope Submit manuscript

Abstract

The mechanisms of the adverse effects of free fatty acids on the ischemic-reperfused myocardium are not fully understood. Long-chain fatty acids, including palmitate, uncouple oxidative phosphorylation and should therefore promote the formation of oxygen-derived free radicals, with consequent adverse effects. Conversely, the antianginal agent trimetazidine (TMZ), known to inhibit cardiac fatty acid oxidation, could hypothetically lessen the formation of reactive oxygen species (ROS) and thus improve reperfusion mechanical function. Isolated perfused rat hearts underwent 30 min of total global ischemia followed by 30 min of reperfusion. Hearts were perfused with glucose 5.5 mmol/l or palmitate 1.5 mmol/l with or without TMZ (100 μmol/l). Ascorbyl free radical (AFR) release during perfusion periods was measured by electron spin resonance as a marker of oxidative stress. Post-ischemic recovery in the palmitate group of heart was lower than in the glucose group with a marked rise in diastolic tension and reduction in left ventricular developed pressure (Glucose: 85 ± 11 mmHg; Palmitate: 10 ± 6 mmHg; p < 0.001). TMZ decreased diastolic tension in both glucose- and in palmitate-perfused hearts. Release of AFR within the first minute of reperfusion was greater in palmitate-perfused hearts and in hearts perfused with either substrate, this marker of oxidative stress was decreased by TMZ (expressed in arbitrary units/ml; respectively: 8.49 ± 1.24 vs. 1.06 ± 0.70 p < 0.05; 12.47 ± 2.49 vs. 3.37 ± 1.29 p < 0.05). Palmitate increased the formation of ROS and reperfusion contracture. TMZ, a potential inhibitor of palmitate-induced mitochondrial uncoupling, decreased the formation of free radicals and improved postischemic mechanical dysfunction. The novel conclusion is that adverse effects of fatty acids on ischemic-reperfusion injury may be mediated, at least in part, by oxygen-derived free radicals.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Bing RJ, Siegel A, Ungar I, Gilbert M: Metabolism of the human heart II. Studies on fat, ketone and amino acid metabolism. Am J Med 16: 504–515, 1954

    Article  CAS  PubMed  Google Scholar 

  2. Opie LH, Evans JR, Shipp JC: Effect of fasting on glucose and palmitate metabolism of perfused rat heart. Am J Physiol 205: 1203–1208, 1963

    CAS  PubMed  Google Scholar 

  3. De Leiris J, Opie LH, Lubbe WF: Effects of free fatty acid and enzyme release in experimental glucose on myocardial infarction. Nature 253: 746–747, 1975

    Article  CAS  PubMed  Google Scholar 

  4. Opie LH: Effect of fatty acids on contractility and rhythm of the heart. Nature 227: 1055–1056, 1970

    CAS  PubMed  Google Scholar 

  5. Ferrari R: Factors influencing the metabolic and functional alterations induced by ischemia and reperfusion. In: R. Ferrari et al. (eds). Myocardial Ischemia and Lipid Metabolism. Plenum Press, New York, 1983, pp 135–137

    Google Scholar 

  6. Oliver MF, Kurien VA, Greenwood TW: Relation between serum-free-fatty acids and arrhythmias and death after acute myocardial infarction. Lancet 1(7545): 710–714, 1968

    CAS  PubMed  Google Scholar 

  7. Lopaschuk GD, Wambolt RB, Barr RL: An imbalance between glycolysis and glucose oxidation is a possible explanation for the detrimental effects of high levels of fatty acids during aerobic reperfusion of ischemic hearts. J Pharmacol Exp Ther 264: 135–144, 1993

    CAS  PubMed  Google Scholar 

  8. Maupoil V, Rochette L: Evaluation of free radical and lipid peroxide formation during global ischemia and reperfusion in isolated perfused rat heart. Cardiovasc Drugs Ther 2: 615–621, 1988

    Article  CAS  PubMed  Google Scholar 

  9. Bolli R: Oxygen-derived free radicals and myocardial reperfusion injury: an overview. Cardiovasc Drugs Ther 5: 249–268, 1991

    PubMed  Google Scholar 

  10. Bernier M, Hearse DJ, Manning AS: Reperfusion-induced arrhythmias and oxygen-derived free radicals. Studies with “anti-free radical” interventions and a free radical-generating system in the isolated perfused rat heart. Circ Res 58: 331–340, 1986

    CAS  PubMed  Google Scholar 

  11. Vergely C, Maupoil V, Benderitter M, Rochette L: Influence of the severity of myocardial ischemia on the intensity of ascorbyl free radical release and on postischemic recovery during reperfusion. Free Radic Biol Med 24: 470–479, 1998

    Article  CAS  PubMed  Google Scholar 

  12. Cantor PF, Lucien A, Kozak R, Lopaschuk, GD: The antianginal drug trimetazidine shifts cardiac energy metabolism from fatty acid oxidation to glucose oxidation by inhibiting mitochondrial long-chain 3-ketoacyl coenzyme A thiolase. Circ Res 86: 580–588, 2000

    Google Scholar 

  13. Monteiro P, Duarte Al, Goncalves LM, Moreno A, Providencia LA: Protective effect of trimetazidine on myocardial mitochondrial function in an ex-vivo model of global myocardial ischemia. Eur J Pharmacol 503: 123–128, 2004

    Article  CAS  PubMed  Google Scholar 

  14. Watts JA, Maiorano PC: Trace amounts of albumin protect against ischemia and reperfusion injury in isolated rat hearts. J Mol Cell Cardiol 31: 1653–1662, 1999

    Article  CAS  PubMed  Google Scholar 

  15. Buettner GR, Jurkiewicz BA: Ascorbate free radical as a marker of oxidative stress: an EPR study. Free Radic Biol Med 14: 49–55, 1993

    Article  CAS  PubMed  Google Scholar 

  16. Lesnefsky EJ, Chen Q, Moghaddas S, Hassan MO, Tandler B, Hoppel CL: Blockade of electron transport during ischemia protects cardiac mitochondria. J Biol Chem 279: 47961–47967, 2004

    Article  CAS  PubMed  Google Scholar 

  17. Lopaschuk GD, Barr R, Thomas PD, Dyck JR: Beneficial effects of trimetazidine in ex vivo working ischemic hearts are due to a stimulation of glucose oxidation secondary to inhibition of long-chain 3-ketoacyl coenzyme a thiolase. Circ Res 93: 26–32, 2003

    Google Scholar 

  18. Pantos C, Bescond-Jacquet A, Tzeis S, Paizis I, Mourouzis I, Moraitis P, Malliopoulou V, Politi ED, Karageorgiou H, Varonos D, Cokkinos DV: TMZ protects isolated rat hearts against ischemia-reperfusion injury in an experimental timing – dependent manner. Basic Res Cardiol 100: 154–160, 2005

    CAS  PubMed  Google Scholar 

  19. Tritto I, Wang P, Kuppusamy P, Giraldez R, Zweier JL, Ambrosio G: The anti-anginal drug trimetazidine reduces neutrophil-mediated cardiac reperfusion injury. J Cardiovasc Pharmacol 46: 89–98, 2005

    Article  CAS  PubMed  Google Scholar 

  20. Maupoil V, Rochette L, Tabard A, Clauser P, Harpey C: Direct measurement of free radical generation in isolated rat heart by electron paramagnetic resonance spectroscopy: effect of trimetazidine. Adv Exp Med Biol 264: 373–376, 1990

    CAS  PubMed  Google Scholar 

  21. Guarnieri C, Muscari C: Anti oxy-radical properties of trimetazidine. Res Commun Chem Pathol Pharmacol 64: 215–225, 1989

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Luc Rochette.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gambert, S., Vergely, C., Filomenko, R. et al. Adverse effects of free fatty acid associated with increased oxidative stress in postischemic isolated rat hearts. Mol Cell Biochem 283, 147–152 (2006). https://doi.org/10.1007/s11010-006-2518-9

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11010-006-2518-9

Keywords

Navigation